title: [Skin infection due to Mycobacterium marinum in a patient being treated with natalizumab].
authors.forename: L
authors.initials: L
authors.lastname: Midaglia
authors.forename: D
authors.initials: D
authors.lastname: Munoz-Garcia
authors.forename: B
authors.initials: B
authors.lastname: Sopena
authors.forename: C
authors.initials: C
authors.lastname: Rodriguez-Cerdeira
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy; D009165:Mycobacterium Infections, Nontuberculous / Q000209:etiology* / Q000382:microbiology*; D019910:Mycobacterium marinum / Q000472:pathogenicity*; D000069442:Natalizumab; D017192:Skin Diseases, Bacterial / Q000209:etiology* / Q000382:microbiology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000069442:Natalizumab